Key result
Disability, cognitive impairment, and polypharmacy reduce medication adherence after stroke, whereas trust in medication and specific educational interventions may improve adherence.
Why the study?
Medication adherence for secondary prevention after stroke is often low, despite an increased risk of stroke recurrence.
What are the mediators, confounders, and effectiveness of interventions for medication adherence after stroke?
What are the mediators, confounders, and effectiveness of interventions for medication adherence after stroke?
Medication adherence after stroke is poor (approximately 30.9% non-adherence), and while organizational interventions improve blood pressure control, improving adherence requires addressing patient trust, treatment burden, and providing tailored education.
Answers are grounded in this paper and cite their sources.
May guide adherence support in stroke survivors with disability or cognitive impairment; hypothesis-generating and requires RCTs before practice change.
After a stroke, people are left with an increased risk of recurrence. One of the primary methods of prevention is the use of a range of medications, but adherence to these is often low. This article evaluates and summarises three systematic reviews that investigate possible underlying reasons for this and how to overcome these barriers.
No takes yet. Share an insight, caveat, or question.
Hill et al. (2020) conducted a review in Stroke or transient ischaemic attack. Organisational and educational interventions vs. Usual care was evaluated on Medication adherence. Disability, cognitive impairment, and polypharmacy reduce medication adherence after stroke, whereas trust in medication and specific educational interventions may improve adherence.
Synapse has enriched 10 related papers. Consider them for comparative context: